TY - JOUR
T1 - Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan
AU - Shiroeda, Hisakazu
AU - Tahara, Tomomitsu
AU - Nakamura, Masakatsu
AU - Shibata, Tomoyuki
AU - Nomura, Tomoe
AU - Yamada, Hideto
AU - Hayashi, Ranji
AU - Saito, Takashi
AU - Yamada, Masayoshi
AU - Fukuyama, Tomoki
AU - Otsuka, Toshimi
AU - Yano, Hirokazu
AU - Ozaki, Kazuaki
AU - Tsuchishima, Mutsumi
AU - Tsutsumi, Mikihiro
AU - Arisawa, Tomiyasu
PY - 2010/8
Y1 - 2010/8
N2 - Macrophage migration inhibitory factor (MIF) is a key proinflammatory mediator. Two functional polymorphisms were identified in the promoter region of MIF gene. We attempted to clarify the associations between these polymorphisms and ulcerative colitis (UC). The study was performed in 111 patients with UC and 209 subjects without UC. We employed the PCR-SSCP method to detect gene polymorphisms. Overall, 5/5-CATT genotype was a decreased risk for the development of UC (OR, 0.51; 95% CI, 0.26-0.99). In addition, 7/7-CATT genotype was significantly associated with chronic continuous phenotype and distal colitis phenotype (OR, 5.49; 95% CI, 1.19-25.3, and OR, 6.10; 95% CI, 1.32-28.2, respectively), whereas 5/5-CATT genotype had an inhibitory effect on the development of UC after 20. years of age (OR, 0.33; 95% CI, 0.14-0.82). On the other hand, G-173C polymorphism did not affect the susceptibility to and the phenotypes of UC. Our results suggested that tetranucleotide CATT repeat of MIF gene promoter may be associated with the development of UC and the severity of inflammation in patients with UC.
AB - Macrophage migration inhibitory factor (MIF) is a key proinflammatory mediator. Two functional polymorphisms were identified in the promoter region of MIF gene. We attempted to clarify the associations between these polymorphisms and ulcerative colitis (UC). The study was performed in 111 patients with UC and 209 subjects without UC. We employed the PCR-SSCP method to detect gene polymorphisms. Overall, 5/5-CATT genotype was a decreased risk for the development of UC (OR, 0.51; 95% CI, 0.26-0.99). In addition, 7/7-CATT genotype was significantly associated with chronic continuous phenotype and distal colitis phenotype (OR, 5.49; 95% CI, 1.19-25.3, and OR, 6.10; 95% CI, 1.32-28.2, respectively), whereas 5/5-CATT genotype had an inhibitory effect on the development of UC after 20. years of age (OR, 0.33; 95% CI, 0.14-0.82). On the other hand, G-173C polymorphism did not affect the susceptibility to and the phenotypes of UC. Our results suggested that tetranucleotide CATT repeat of MIF gene promoter may be associated with the development of UC and the severity of inflammation in patients with UC.
UR - http://www.scopus.com/inward/record.url?scp=77954086857&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954086857&partnerID=8YFLogxK
U2 - 10.1016/j.cyto.2010.05.003
DO - 10.1016/j.cyto.2010.05.003
M3 - Article
C2 - 20621719
AN - SCOPUS:77954086857
SN - 1043-4666
VL - 51
SP - 173
EP - 177
JO - Cytokine
JF - Cytokine
IS - 2
ER -